PUBLISHER: The Business Research Company | PRODUCT CODE: 1948650
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948650
Wearable injectors are specialized drug delivery devices that affix to the patient's body during the subcutaneous administration of drugs over a predetermined duration.
These wearable injectors come in two primary types are on-body injectors and off-body injectors. On-body injectors are drug delivery devices attached directly to the patient's skin, typically on the abdomen or the back of the patient's arm. They find applications in various medical fields, including immuno-oncology, diabetes, cardiovascular diseases, among others, and are employed across a range of healthcare settings, including hospitals, clinics, and home care.
Tariffs are impacting the wearable injectors market by increasing costs of imported microelectronics, sensors, polymer housings, adhesive materials, and precision drug delivery components. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on specialized imported parts, while Asia-Pacific faces higher export-related cost pressures. These tariffs are increasing device production costs and slowing large-scale deployment. However, they are also supporting domestic manufacturing expansion, regional supply chain development, and innovation in modular and cost-optimized injector designs.
The wearable injectors market research report is one of a series of new reports from The Business Research Company that provides wearable injectors market statistics, including wearable injectors industry global market size, regional shares, competitors with a wearable injectors market share, detailed wearable injectors market segments, market trends and opportunities, and any further data you may need to thrive in the wearable injectors industry. This wearable injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wearable injectors market size has grown rapidly in recent years. It will grow from $9.84 billion in 2025 to $11.32 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising biologics and large-molecule drug usage, expansion of self-administration therapies, advancements in drug formulation technologies, growing acceptance of wearable drug delivery devices.
The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $19.77 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, rising focus on home healthcare delivery, expansion of connected drug delivery platforms, growing demand for long-duration injectors, increasing integration of digital health ecosystems. Major trends in the forecast period include increasing adoption of on-body drug delivery systems, rising demand for controlled and continuous drug administration, growing integration of smart connectivity features, expansion of home-based injectable therapies, enhanced focus on patient adherence solutions.
The rise in the prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancers has significantly contributed to the growth of the wearable injectors market. For example, in April 2023, a report from the British Diabetic Association, a UK-based charity supporting individuals with diabetes, highlighted that approximately 4.3 million people in the UK are diagnosed with diabetes. Of these, around 90% have type 2 diabetes, about 8% are diagnosed with type 1 diabetes, and the remaining 2% have other forms of diabetes. The increasing number of patients with diabetes and other chronic conditions has led to a greater demand for treatment solutions, driving the expansion of the wearable injectors market.
Major companies operating in the voice prosthesis devices and equipment market are emphasizing technological advancements, such as AI-enabled bioelectric wearable systems integrated with magnetoelastic sensing, to support speech restoration in patients with vocal cord impairment. AI-assisted bioelectric wearable systems capture subtle laryngeal muscle movements beneath the skin and transform these signals into clear, audible speech, offering a non-invasive solution for individuals with voice disorders resulting from conditions such as laryngeal cancer, vocal cord damage, or surgical removal. For instance, in March 2024, UCLA Samueli School of Engineering, a US-based bioengineering research institution, developed a soft, patch-like AI-powered wearable device designed to adhere to the skin near the throat. The device integrates a self-powered magnetoelastic sensing element with a machine-learning algorithm to identify laryngeal muscle activity and convert it into near-natural speech with 95% accuracy. Lightweight, flexible, and reusable, this innovation enables patients with impaired vocal cords to communicate effectively without invasive interventions, representing a major advancement in voice prosthesis technology.
In June 2023, LTS LOHMANN Therapie-Systeme AG, a pharmaceutical company based in Germany, purchased the Sorrel wearable injection device business from Eitan Medical for an undisclosed sum. This acquisition is anticipated to broaden LTS LOHMANN Therapie-Systeme AG's range of drug delivery platforms and enhance its offerings in the areas of large molecules and biologics. Eitan Medical Ltd. is an Israeli medical device company known for its development of innovative drug delivery solutions, including wearable injectors.
Major companies operating in the wearable injectors market are Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Consort Medical plc, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation
North America was the largest region in the wearable injectors market in 2025. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the wearable injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The wearable injectors market consists of sales of instruments such as on-body injectors and off-body injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Wearable Injectors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses wearable injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for wearable injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable injectors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.